BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

FOUNDATION FOR SARCOIDOSIS RESEARCH — Receipts Report

LD-2 disclosure · Registration - Amendment

FOUNDATION FOR SARCOIDOSIS RESEARCH

via HEALTH AND MEDICINE COUNSEL

2nd Quarter (Apr 1 - June 30) · 2024Posted Jan 28, 2025Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: FOUNDATION FOR SARCOIDOSIS RESEARCH
Description: Patient driven foundation advancing sarcoidosis care
Location: Illinois · United States of America

Registrant

Firm: HEALTH AND MEDICINE COUNSEL
Description: Governmentrelations lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Health Issues
FY25; SR awareness, funding and patient advocacy.
LobbyistsDANE CHRISTIANSEN · PHILIP GOGLAS ii · KIRA FLAHERTY
Budget/Appropriations
FY25; SR awareness, funding and patient advocacy.
LobbyistsDANE CHRISTIANSEN · PHILIP GOGLAS ii · KIRA FLAHERTY

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.